REZOLUTE, INC. Public Float
REZOLUTE, INC. (RZLT) had Public Float of $203.92 million as of 2025-12-31, per its 10-K filed 2026-09-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-09-24
- 2025-12-31: Entity Public Float $203.92M.
- 2024-12-31: Entity Public Float $258.83M.
- 2023-12-29: Entity Public Float $33.25M.
- 2022-12-31: Entity Public Float $63.58M.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $203.92M 10-K · filed 2026-09-24 |
| 2024-12-31 | $258.83M 10-K · filed 2025-09-17 |
| 2023-12-29 | $33.25M 10-K · filed 2024-09-19 |
| 2022-12-31 | $63.58M 10-K · filed 2023-09-14 |
| 2021-12-31 | $60.99M 10-K · filed 2022-09-15 |
| 2020-12-31 | $75.93M 10-K · filed 2021-09-15 |
| 2019-12-31 | $12.60M 10-K · filed 2020-10-13 |
| 2018-12-31 | $4.08M 10-K · filed 2019-09-10 |
| 2017-12-31 | $47.19M 10-K · filed 2018-10-15 |
| 2016-12-31 | $35.45M 10-K · filed 2017-09-22 |
| 2015-12-31 | $31.44M 10-K · filed 2016-09-28 |
| 2014-12-31 | $23.62M 10-K · filed 2015-09-28 |
| 2013-12-31 | $2.77M 10-K · filed 2014-09-30 |
| 2012-12-31 | $39.30K 10-K · filed 2013-09-11 |
| 2012-09-28 | $39.30K 10-K/A · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |